144 related articles for article (PubMed ID: 9416565)
1. Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase.
Prescott SM
J Investig Allergol Clin Immunol; 1997; 7(5):416. PubMed ID: 9416565
[No Abstract] [Full Text] [Related]
2. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.
Elstad MR; Stafforini DM; McIntyre TM; Prescott SM; Zimmerman GA
J Biol Chem; 1989 May; 264(15):8467-70. PubMed ID: 2722780
[TBL] [Abstract][Full Text] [Related]
3. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Dulioust A; Hilliquin P; Menkes CJ; Benveniste J; Arnoux B
Scand J Rheumatol; 1992; 21(4):161-4. PubMed ID: 1529281
[TBL] [Abstract][Full Text] [Related]
4. PAF and PAF acetylhydrolase in the nervous system.
Hattori M; Aoki J; Arai H; Inoue K
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):99-102. PubMed ID: 8906551
[TBL] [Abstract][Full Text] [Related]
5. PAF and haematopoiesis: V. Platelet-activating factor and acetylhydrolase in human femoral bone marrow.
Denizot Y; Charissoux JL; Nathan N; Praloran V
J Lipid Mediat Cell Signal; 1995 Jul; 12(1):45-7. PubMed ID: 7551688
[No Abstract] [Full Text] [Related]
6. Platelet-activating factor acetylhydrolase activity in bovine seminal plasma.
Parks JE; Hough SR
J Androl; 1993; 14(5):335-9. PubMed ID: 8288488
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor acetylhydrolase in human seminal plasma.
Letendre ED; Miron P; Roberts KD; Langlais J
Fertil Steril; 1992 Jan; 57(1):193-8. PubMed ID: 1730316
[TBL] [Abstract][Full Text] [Related]
8. Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models.
Fukuda Y; Kawashima H; Saito K; Inomata N; Matsui M; Nakanishi T
Eur J Pharmacol; 2000 Feb; 390(1-2):203-7. PubMed ID: 10708725
[TBL] [Abstract][Full Text] [Related]
9. Implication of PAF and acetylhydrolase (PAF-AH) activity in periodontal disease.
Baltas G; Kotsifaki H; Antonopoulou S; Kipioti A; Demopoulos CA
Adv Exp Med Biol; 1996; 416():135-41. PubMed ID: 9131139
[No Abstract] [Full Text] [Related]
10. Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis.
Hemmings R; Miron P; Falcone T; Bourque J; Lepage N; Langlais J
Obstet Gynecol; 1993 Feb; 81(2):276-9. PubMed ID: 8423963
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.
Tjoelker LW; Wilder C; Eberhardt C; Stafforini DM; Dietsch G; Schimpf B; Hooper S; Le Trong H; Cousens LS; Zimmerman GA; Yamada Y; McIntyre TM; Prescott SM; Gray PW
Nature; 1995 Apr; 374(6522):549-53. PubMed ID: 7700381
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) acetylhydrolase activity, LIS1 expression, and seizures.
Shmueli O; Cahana A; Reiner O
J Neurosci Res; 1999 Jul; 57(2):176-84. PubMed ID: 10398295
[TBL] [Abstract][Full Text] [Related]
13. A PAF-acetylhydrolase activity in Tetrahymena pyriformis cells.
Tselepis AD; Lekka ME; Tsoukatos D
FEBS Lett; 1991 Aug; 288(1-2):147-50. PubMed ID: 1908796
[TBL] [Abstract][Full Text] [Related]
14. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
Jehle R; Schlame M; Büttner C; Frey B; Sinha P; Rüstow B
Biochim Biophys Acta; 2001 May; 1532(1-2):60-6. PubMed ID: 11420174
[TBL] [Abstract][Full Text] [Related]
16. Familial hypercholesterolaemia and platelet-activating factor acetylhydrolase: difference between the homozygous and heterozygous form.
Napoli C
Eur J Clin Invest; 1998 Jun; 28(6):506-9. PubMed ID: 9693945
[No Abstract] [Full Text] [Related]
17. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
Ambrosio G; Oriente A; Napoli C; Palumbo G; Chiariello P; Marone G; Condorelli M; Chiariello M; Triggiani M
J Clin Invest; 1994 Jun; 93(6):2408-16. PubMed ID: 8200975
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor acetylhydrolases in health and disease.
Tjoelker LW; Stafforini DM
Biochim Biophys Acta; 2000 Oct; 1488(1-2):102-23. PubMed ID: 11080681
[TBL] [Abstract][Full Text] [Related]
19. Altered platelet-activating factor levels and acetylhydrolase activities are associated with increasing severity of bronchopulmonary dysplasia.
Gaylord MS; Smith ZL; Lorch V; Blank ML; Snyder F
Am J Med Sci; 1996 Oct; 312(4):149-54. PubMed ID: 8853062
[TBL] [Abstract][Full Text] [Related]
20. PAF and haematopoiesis XII: macrophage colony-stimulating factor (M-CSF) decreases platelet-activating factor (PAF) acetylhydrolase production in macrophagic J774 cells.
Dupuis F; Dulery C; Praloran V; Denizot Y
Cancer Lett; 1996 Oct; 107(2):199-204. PubMed ID: 8947513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
